Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al

Circ Arrhythm Electrophysiol. 2013 Aug;6(4):e66. doi: 10.1161/CIRCEP.113.000701.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / administration & dosage*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / surgery*
  • Benzimidazoles / administration & dosage*
  • Female
  • Humans
  • Male
  • Thromboembolism / prevention & control*
  • Warfarin / administration & dosage*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Warfarin